Ectoparasiticide [EPC]

Ectoparasiticide [EPC] was reported 3918 times

Drugs of the Ectoparasiticide [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 EYELID SEBORRHOEIC KERATOSIS 1 1.0000
1 OCULAR DEMODICOSIS 26 0.5417
2 DEMODEX BLEPHARITIS 5 0.5000
3 ACARIASIS 4 0.2857
4 ARTHROPOD INFESTATION 16 0.2162
5 DOSING ERROR 25 0.1488
6 PUNCTATE KERATOSIS 1 0.1429
7 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 30 0.1266
8 INSTILLATION SITE IRRITATION 149 0.1258
9 INSTILLATION SITE WARMTH 1 0.1111
10 SUSPECTED PRODUCT CONTAMINATION 111 0.1096
11 CONJUNCTIVAL PAPILLAE 2 0.1000
12 EYELID DISCOLOURATION 5 0.0980
13 EYE ABRASION 4 0.0755
14 BULLOUS KERATOPATHY 1 0.0714
15 SPLEEN ISCHAEMIA 1 0.0500
16 INSTILLATION SITE SWELLING 8 0.0457
17 INSTILLATION SITE PRURITUS 15 0.0398
18 CHALAZION 25 0.0390
19 NEUROTROPHIC KERATOPATHY 2 0.0370
20 INSTILLATION SITE INFLAMMATION 2 0.0357
21 INSTILLATION SITE ERYTHEMA 17 0.0322
22 PERIORBITAL IRRITATION 11 0.0322
23 CONJUNCTIVAL FOLLICLES 1 0.0312
24 OCULAR CYST 2 0.0270
25 PERIORBITAL DERMATITIS 2 0.0256
26 VENIPUNCTURE 1 0.0233
27 HEPATITIS B ANTIBODY ABNORMAL 1 0.0217
28 EYELID MARGIN CRUSTING 61 0.0211
29 NASAL MUCOSAL BLISTERING 1 0.0185
30 BLOOD CAFFEINE INCREASED 1 0.0179
31 HORDEOLUM 77 0.0178
32 SWELLING OF NOSE 3 0.0174
33 STEM CELL THERAPY 1 0.0169
34 SWELLING OF EYELID 105 0.0167
35 PUNCTATE KERATITIS 15 0.0163
36 PSEUDOFOLLICULITIS 1 0.0159
37 EYELID IRRITATION 39 0.0155
38 INSTILLATION SITE DRYNESS 2 0.0155
39 INSTILLATION SITE DISCOMFORT 2 0.0149
40 ERYTHEMA OF EYELID 80 0.0148
41 MALFORMATION VENOUS 1 0.0143
42 EYELID EXFOLIATION 11 0.0139
43 INSTILLATION SITE FOREIGN BODY SENSATION 2 0.0138
44 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
45 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
46 ECZEMA EYELIDS 7 0.0125
47 HAEMATOTYMPANUM 1 0.0118
48 BLEPHARITIS 46 0.0115
49 EYE OPACITY 1 0.0109
50 SUSPECTED PRODUCT TAMPERING 6 0.0107
51 SCLERAL PIGMENTATION 1 0.0105
52 ERYTHROPSIA 1 0.0102
53 OCULAR ROSACEA 2 0.0099
54 CORNEAL INFILTRATES 3 0.0096
55 CORNEAL TOXICITY 1 0.0090
56 EYELID PAIN 18 0.0088
57 THERMAL BURNS OF EYE 2 0.0088
58 PERONEAL NERVE INJURY 1 0.0088
59 PRODUCT OUTER PACKAGING ISSUE 8 0.0088
60 KERATORHEXIS 1 0.0088
61 EYE DISCHARGE 89 0.0086
62 EYE IRRITATION 491 0.0085
63 MYOKYMIA 1 0.0083
64 EYELID DISORDER 19 0.0082
65 LACRIMATION DISORDER 1 0.0082
66 ONYCHOMALACIA 1 0.0080
67 PRODUCT DELIVERY MECHANISM ISSUE 43 0.0080
68 PERIORBITAL SWELLING 44 0.0078
69 PRODUCT PRESCRIBING ISSUE 167 0.0077
70 FOREIGN BODY SENSATION IN EYES 46 0.0072
71 OPHTHALMIC MIGRAINE 5 0.0072
72 EYELID RASH 7 0.0072
73 PERIORBITAL PAIN 6 0.0071
74 EYELID THICKENING 2 0.0070
75 OCULAR HYPERAEMIA 322 0.0068
76 OCULAR DISCOMFORT 75 0.0067
77 DACRYOCYSTITIS 1 0.0065
78 EYELIDS PRURITUS 20 0.0064
79 INCREASED DOSE ADMINISTERED 2 0.0064
80 EYE PARAESTHESIA 1 0.0064
81 EYE PRURITUS 214 0.0064
82 SKIN TEXTURE ABNORMAL 6 0.0063
83 INSTILLATION SITE PAIN 15 0.0060
84 DYSCHROMATOPSIA 5 0.0060
85 ECTROPION 2 0.0059
86 SPLENIC THROMBOSIS 1 0.0059
87 GLARE 3 0.0058
88 SCABIES 1 0.0058
89 EYELASH CHANGES 1 0.0056
90 GLASSY EYES 4 0.0056
91 MILIA 2 0.0055
92 LID SULCUS DEEPENED 2 0.0054
93 OPHTHALMIC HERPES SIMPLEX 3 0.0052
94 DEVICE COLOUR ISSUE 2 0.0050
95 EYE PAIN 277 0.0049
96 PERIORBITAL DISORDER 1 0.0049
97 LACRIMATION INCREASED 144 0.0048
98 MICROGRAPHIC SKIN SURGERY 1 0.0047
99 PERIPHERAL NERVE OPERATION 1 0.0046
100 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
101 LACRIMATION DECREASED 2 0.0042
102 PARANASAL SINUS HYPOSECRETION 1 0.0040
103 EYELID CYST 1 0.0039
104 EXPOSURE TO CONTAMINATED DEVICE 1 0.0038
105 INSTILLATION SITE DISCHARGE 1 0.0038
106 GROWTH OF EYELASHES 3 0.0038
107 PERIORBITAL CELLULITIS 2 0.0037
108 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
109 SCLERAL DISORDER 1 0.0037
110 EXPOSURE VIA SKIN CONTACT 96 0.0037
111 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
112 PRODUCT EXPIRATION DATE ISSUE 5 0.0036
113 THERAPY INTERRUPTED 253 0.0035
114 BURNING MOUTH SYNDROME 2 0.0035
115 EYE SWELLING 130 0.0035
116 ABNORMAL SENSATION IN EYE 15 0.0035
117 ASTHENOPIA 19 0.0035
118 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
119 CONJUNCTIVITIS ALLERGIC 5 0.0034
120 SYSTEMIC MASTOCYTOSIS 1 0.0033
121 EYELID SKIN DRYNESS 4 0.0033
122 PUPILLARY DISORDER 2 0.0033
123 EYE ABSCESS 1 0.0033
124 INTERCEPTED PRODUCT STORAGE ERROR 11 0.0031
125 GINGIVAL DISCOMFORT 2 0.0030
126 DRUG THERAPY 1 0.0029
127 CONJUNCTIVITIS BACTERIAL 1 0.0029
128 PHOTOPHOBIA 55 0.0029
129 CONJUNCTIVAL OEDEMA 3 0.0029
130 SPORTS INJURY 1 0.0029
131 FACIAL DISCOMFORT 2 0.0028
132 PRODUCT USE COMPLAINT 44 0.0028
133 EXPOSURE VIA INGESTION 7 0.0028
134 GLOBULINS INCREASED 1 0.0027
135 METAMORPHOPSIA 5 0.0027
136 XANTHOPSIA 1 0.0027
137 EXCESSIVE EYE BLINKING 4 0.0027
138 KERATOCONUS 1 0.0027
139 HALO VISION 3 0.0027
140 CHROMATOPSIA 2 0.0026
141 KERATITIS 8 0.0026
142 CAPILLARY DISORDER 1 0.0026
143 MADAROSIS 29 0.0025
144 VIRAL PHARYNGITIS 1 0.0025
145 TRANSPLANTATION COMPLICATION 1 0.0024
146 BLEPHAROSPASM 15 0.0024
147 DRY EYE 115 0.0023
148 SKIN LAXITY 1 0.0023
149 EYELID INFECTION 1 0.0023
150 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
151 LIQUID PRODUCT PHYSICAL ISSUE 16 0.0022
152 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0022
153 PHARYNGEAL HYPOAESTHESIA 2 0.0022
154 EHLERS-DANLOS SYNDROME 1 0.0022
155 PYOGENIC GRANULOMA 1 0.0021
156 EYE INFLAMMATION 20 0.0021
157 DARK CIRCLES UNDER EYES 3 0.0020
158 DRAINAGE 1 0.0020
159 INTRAOCULAR LENS IMPLANT 1 0.0020
160 HYPERMOBILITY SYNDROME 1 0.0020
161 ASTIGMATISM 3 0.0020
162 ORBITAL OEDEMA 1 0.0020
163 EYE COLOUR CHANGE 2 0.0020
164 PATELLOFEMORAL PAIN SYNDROME 1 0.0019
165 DEVICE BREAKAGE 79 0.0019
166 VISION BLURRED 267 0.0019
167 INJURY CORNEAL 1 0.0019
168 EYE CONTUSION 4 0.0019
169 PRODUCT LOT NUMBER ISSUE 4 0.0018
170 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
171 EYE INFECTION BACTERIAL 1 0.0018
172 CORNEAL OEDEMA 4 0.0018
173 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 11 0.0018
174 OCCIPITAL NEURALGIA 1 0.0018
175 PRODUCT CONTAINER ISSUE 15 0.0017
176 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
177 EYE ULCER 1 0.0017
178 CORNEAL EPITHELIUM DEFECT 1 0.0017
179 REBOUND PSORIASIS 1 0.0017
180 HYPOAESTHESIA EYE 1 0.0017
181 EYE LASER SURGERY 1 0.0017
182 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
183 PRODUCT USE ISSUE 315 0.0017
184 SYMPTOM RECURRENCE 10 0.0017
185 CYANOPSIA 1 0.0017
186 PARANASAL SINUS DISCOMFORT 6 0.0016
187 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
188 HYPOTRICHOSIS 1 0.0016
189 MITE ALLERGY 1 0.0015
190 EXTRA DOSE ADMINISTERED 61 0.0015
191 SCLERAL HYPERAEMIA 1 0.0015
192 CORNEAL OPACITY 2 0.0015
193 LICHEN SCLEROSUS 1 0.0015
194 ULCERATIVE KERATITIS 4 0.0015
195 EPISCLERITIS 1 0.0014
196 EYE INFECTION 16 0.0014
197 CERVICAL RADICULOPATHY 1 0.0014
198 PRODUCT DESIGN ISSUE 1 0.0014
199 ATROPHIC VULVOVAGINITIS 1 0.0014
200 ORAL MUCOSAL ERYTHEMA 2 0.0013
201 SINUS PAIN 3 0.0013
202 INFECTION PARASITIC 1 0.0013
203 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
204 CORNEAL TRANSPLANT 1 0.0013
205 PRODUCT INEFFECTIVE 1 0.0013
206 MYOPIA 3 0.0013
207 SCLERITIS 2 0.0012
208 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 252 0.0012
209 REACTION TO PRESERVATIVES 1 0.0012
210 TONGUE ERYTHEMA 1 0.0012
211 LUNG OPERATION 1 0.0012
212 LIP PRURITUS 1 0.0012
213 GINGIVAL ERYTHEMA 1 0.0012
214 ENDOCRINE OPHTHALMOPATHY 1 0.0012
215 PRODUCT CONTAMINATION 4 0.0011
216 CONJUNCTIVAL HYPERAEMIA 4 0.0011
217 ACCIDENTAL EXPOSURE TO PRODUCT 115 0.0011
218 NUCHAL RIGIDITY 1 0.0011
219 PRODUCT APPEARANCE CONFUSION 1 0.0011
220 THERAPY CESSATION 54 0.0011
221 PRODUCT AFTER TASTE 1 0.0010
222 VASCULAR PAIN 1 0.0010
223 FOREIGN BODY IN EYE 1 0.0010
224 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
225 MOTION SICKNESS 2 0.0010
226 TELANGIECTASIA 1 0.0010
227 SPUTUM RETENTION 1 0.0010
228 FACIAL PAIN 9 0.0010
229 DERMATITIS CONTACT 11 0.0010
230 DEVICE MATERIAL ISSUE 2 0.0010
231 TONGUE DISCOMFORT 4 0.0009
232 INNER EAR DISORDER 1 0.0009
233 IDIOPATHIC URTICARIA 1 0.0009
234 PRODUCT STORAGE ERROR 81 0.0009
235 CONDITION AGGRAVATED 280 0.0009
236 INSTILLATION SITE REACTION 1 0.0009
237 SUBRETINAL FLUID 1 0.0009
238 VITREOUS FLOATERS 9 0.0009
239 CORNEAL DISORDER 2 0.0009
240 NASAL DISCOMFORT 7 0.0009
241 READING DISORDER 2 0.0009
242 BLOODY DISCHARGE 1 0.0009
243 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
244 CHEMICAL BURN 1 0.0009
245 EYE OPERATION 4 0.0009
246 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
247 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
248 THERAPEUTIC RESPONSE DECREASED 51 0.0008
249 PNEUMONIA INFLUENZAL 1 0.0008
250 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
251 PARAESTHESIA ORAL 12 0.0008
252 RECTAL PROLAPSE 1 0.0008
253 WRONG DOSE 2 0.0008
254 HAEMATOLOGICAL INFECTION 2 0.0008
255 VESTIBULAR DISORDER 1 0.0008
256 CONJUNCTIVITIS 15 0.0008
257 VASODILATATION 2 0.0008
258 RETINAL ARTERY OCCLUSION 2 0.0008
259 PHOTOPSIA 5 0.0008
260 FRACTURED COCCYX 1 0.0008
261 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
262 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
263 DEVICE DELIVERY SYSTEM ISSUE 21 0.0008
264 EYE DISORDER 25 0.0008
265 BURNING SENSATION 53 0.0008
266 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
267 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
268 EYE HAEMORRHAGE 10 0.0007
269 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
270 SKIN DISCOMFORT 2 0.0007
271 BLOOD SODIUM INCREASED 2 0.0007
272 PRODUCT PACKAGING ISSUE 7 0.0007
273 TONGUE DRY 1 0.0007
274 CORNEAL ABRASION 1 0.0007
275 IMMUNOGLOBULINS DECREASED 1 0.0007
276 DISCHARGE 1 0.0007
277 CHRONIC FATIGUE SYNDROME 1 0.0007
278 NOROVIRUS INFECTION 1 0.0007
279 PRODUCT COMMUNICATION ISSUE 6 0.0007
280 THERAPY NON-RESPONDER 30 0.0007
281 PHOTOSENSITIVITY REACTION 11 0.0007
282 IRITIS 2 0.0007
283 DIPLOPIA 17 0.0007
284 RUBBER SENSITIVITY 1 0.0007
285 ORAL DISCOMFORT 9 0.0006
286 EYE ALLERGY 1 0.0006
287 ROSACEA 3 0.0006
288 BRAIN FOG 10 0.0006
289 KERATOPATHY 1 0.0006
290 PHARYNGEAL PARAESTHESIA 1 0.0006
291 NIGHT BLINDNESS 1 0.0006
292 SKIN EROSION 2 0.0006
293 SHOULDER FRACTURE 1 0.0006
294 VISUAL IMPAIRMENT 75 0.0006
295 INABILITY TO AFFORD MEDICATION 6 0.0006
296 PRODUCT COLOUR ISSUE 3 0.0006
297 FIXED ERUPTION 1 0.0006
298 MYCOBACTERIAL INFECTION 1 0.0006
299 PERIORBITAL OEDEMA 3 0.0006
300 FORMICATION 4 0.0006
301 OTORRHOEA 1 0.0006
302 EAR PRURITUS 2 0.0006
303 SWELLING FACE 36 0.0006
304 CONTRAST MEDIA ALLERGY 1 0.0005
305 DISORGANISED SPEECH 1 0.0005
306 PRODUCT LEAKAGE 3 0.0005
307 NASAL OBSTRUCTION 1 0.0005
308 IMPATIENCE 1 0.0005
309 HYPOAESTHESIA ORAL 8 0.0005
310 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
311 INTENTIONAL DOSE OMISSION 15 0.0005
312 RETINAL OEDEMA 1 0.0005
313 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
314 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
315 OCULAR HYPERTENSION 1 0.0005
316 JOINT NOISE 1 0.0005
317 OESOPHAGEAL PAIN 2 0.0005
318 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
319 REBOUND ATOPIC DERMATITIS 1 0.0005
320 INTRACRANIAL ANEURYSM 2 0.0005
321 CARDIAC DISCOMFORT 1 0.0005
322 PRODUCT ADMINISTRATION ERROR 10 0.0005
323 DEVICE DEPOSIT ISSUE 1 0.0005
324 OFF LABEL USE 417 0.0005
325 URINARY BLADDER HAEMORRHAGE 1 0.0005
326 EAR SWELLING 1 0.0005
327 VITREOUS DETACHMENT 1 0.0005
328 CHAPPED LIPS 2 0.0005
329 TONGUE DISCOLOURATION 2 0.0005
330 MIDDLE EAR EFFUSION 1 0.0005
331 DANDRUFF 1 0.0005
332 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
333 TONGUE BLISTERING 1 0.0004
334 PRODUCT PHYSICAL ISSUE 9 0.0004
335 PERIARTHRITIS 1 0.0004
336 HAEMATOCRIT INCREASED 1 0.0004
337 INTERCEPTED MEDICATION ERROR 2 0.0004
338 DERMATITIS 9 0.0004
339 SWOLLEN TONGUE 13 0.0004
340 DEVICE LEAKAGE 18 0.0004
341 PAINFUL RESPIRATION 1 0.0004
342 RASH VESICULAR 2 0.0004
343 LYMPHADENITIS 1 0.0004
344 DEVICE ISSUE 37 0.0004
345 PHARYNGEAL SWELLING 4 0.0004
346 EYE OEDEMA 1 0.0004
347 BLINDNESS TRANSIENT 3 0.0004
348 RETINAL TEAR 1 0.0004
349 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
350 DEVICE INFUSION ISSUE 1 0.0004
351 ADVERSE DRUG REACTION 36 0.0004
352 CHEMICAL BURN OF SKIN 1 0.0004
353 TASTE DISORDER 8 0.0004
354 ENDODONTIC PROCEDURE 1 0.0004
355 EAR DISCOMFORT 4 0.0004
356 DRUG TITRATION ERROR 1 0.0004
357 ERYTHEMA 78 0.0004
358 DEVICE DIFFICULT TO USE 25 0.0004
359 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
360 ADVERSE REACTION 5 0.0004
361 ANIMAL BITE 1 0.0004
362 EAR CONGESTION 1 0.0004
363 ABDOMINAL RIGIDITY 1 0.0004
364 MIGRAINE WITH AURA 1 0.0004
365 SKIN WRINKLING 1 0.0004
366 RHINALGIA 1 0.0004
367 RED BLOOD CELL COUNT INCREASED 1 0.0004
368 LIP SWELLING 12 0.0004
369 THERAPEUTIC RESPONSE DELAYED 1 0.0004
370 ELECTRIC SHOCK SENSATION 1 0.0004
371 THROAT IRRITATION 16 0.0004
372 SKIN IRRITATION 16 0.0003
373 LIP PAIN 1 0.0003
374 IMPAIRED QUALITY OF LIFE 5 0.0003
375 VITAMIN B12 DECREASED 1 0.0003
376 EYELID OEDEMA 4 0.0003
377 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
378 STRABISMUS 1 0.0003
379 ENERGY INCREASED 2 0.0003
380 CATARACT OPERATION 2 0.0003
381 DISEASE RECURRENCE 16 0.0003
382 THROAT TIGHTNESS 9 0.0003
383 LIP DRY 3 0.0003
384 EYE INJURY 1 0.0003
385 PROSTATITIS 1 0.0003
386 MASTICATION DISORDER 1 0.0003
387 THERAPY PARTIAL RESPONDER 5 0.0003
388 SECRETION DISCHARGE 4 0.0003
389 INTRAOCULAR PRESSURE INCREASED 4 0.0003
390 EXPOSURE TO TOXIC AGENT 1 0.0003
391 DISCOMFORT 19 0.0003
392 LYMPHOCYTE COUNT INCREASED 1 0.0003
393 BREAST ENLARGEMENT 1 0.0003
394 DEAFNESS NEUROSENSORY 1 0.0003
395 SUSPECTED COVID-19 1 0.0003
396 PRODUCT FORMULATION ISSUE 2 0.0003
397 CORONAVIRUS INFECTION 2 0.0003
398 SKIN INJURY 1 0.0003
399 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
400 TONGUE ULCERATION 1 0.0003
401 WOUND DEHISCENCE 1 0.0003
402 PRODUCT LABEL ISSUE 2 0.0003
403 PRODUCT ODOUR ABNORMAL 3 0.0003
404 HANGOVER 1 0.0003
405 GLOSSITIS 1 0.0003
406 SKIN WEEPING 1 0.0003
407 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
408 FREEZING PHENOMENON 1 0.0003
409 PAROSMIA 2 0.0003
410 TENDON PAIN 2 0.0003
411 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
412 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
413 HYPERSENSITIVITY 47 0.0003
414 SINUS DISORDER 5 0.0003
415 CEREBRAL ATROPHY 1 0.0003
416 MUSCLE HAEMORRHAGE 1 0.0002
417 TRIGEMINAL NEURALGIA 1 0.0002
418 RHINITIS 2 0.0002
419 PRURITUS 95 0.0002
420 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
421 SELF-MEDICATION 1 0.0002
422 SPINAL STENOSIS 1 0.0002
423 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
424 SENSATION OF FOREIGN BODY 2 0.0002
425 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
426 INTERVERTEBRAL DISC DISORDER 1 0.0002
427 MYDRIASIS 3 0.0002
428 PRODUCT DISPENSING ISSUE 1 0.0002
429 TENSION HEADACHE 1 0.0002
430 RHINORRHOEA 15 0.0002
431 OCULAR ICTERUS 1 0.0002
432 ONYCHOMYCOSIS 1 0.0002
433 APPLICATION SITE PAIN 5 0.0002
434 LIGAMENT RUPTURE 1 0.0002
435 PURPURA 2 0.0002
436 RHINITIS ALLERGIC 1 0.0002
437 QUALITY OF LIFE DECREASED 3 0.0002
438 SKIN BURNING SENSATION 16 0.0002
439 SINUS CONGESTION 3 0.0002
440 OROPHARYNGEAL DISCOMFORT 2 0.0002
441 VASCULAR DEVICE INFECTION 1 0.0002
442 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
443 APHONIA 3 0.0002
444 PERFORMANCE STATUS DECREASED 1 0.0002
445 BLISTER 12 0.0002
446 YELLOW SKIN 1 0.0002
447 BLINDNESS UNILATERAL 3 0.0002
448 SKIN TIGHTNESS 1 0.0002
449 EXPIRED PRODUCT ADMINISTERED 7 0.0002
450 DYSPHONIA 12 0.0002
451 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
452 INCORRECT DOSAGE ADMINISTERED 1 0.0002
453 BREATH SOUNDS ABNORMAL 1 0.0002
454 INFLAMMATORY MARKER INCREASED 1 0.0002
455 SKIN EXFOLIATION 17 0.0002
456 INJECTION SITE INFLAMMATION 1 0.0002
457 RASH MACULAR 7 0.0002
458 URTICARIA 33 0.0002
459 EYELID PTOSIS 2 0.0002
460 PALPITATIONS 23 0.0002
461 OROPHARYNGEAL PAIN 18 0.0002
462 VARICOSE VEIN 1 0.0002
463 TENDERNESS 2 0.0002
464 PETECHIAE 2 0.0002
465 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
466 RASH ERYTHEMATOUS 9 0.0002
467 IMPAIRED WORK ABILITY 4 0.0002
468 CHEILITIS 1 0.0002
469 HIP SURGERY 1 0.0002
470 DEAFNESS UNILATERAL 1 0.0002
471 CHOKING SENSATION 1 0.0002
472 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
473 HEADACHE 111 0.0002
474 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
475 PERONEAL NERVE PALSY 1 0.0002
476 DIZZINESS 87 0.0002
477 ADVERSE EVENT 16 0.0002
478 MOUTH SWELLING 1 0.0002
479 PRODUCT LABEL CONFUSION 1 0.0002
480 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
481 CARDIAC PACEMAKER INSERTION 1 0.0002
482 ODYNOPHAGIA 1 0.0002
483 WRIST FRACTURE 2 0.0002
484 RASH PRURITIC 9 0.0002
485 BURSITIS 2 0.0002
486 INGUINAL HERNIA 1 0.0002
487 PRODUCT DOSE OMISSION ISSUE 48 0.0002
488 INJECTION SITE URTICARIA 4 0.0002
489 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
490 DYSGEUSIA 12 0.0002
491 HAIR COLOUR CHANGES 2 0.0002
492 RASH 70 0.0002
493 AGEUSIA 4 0.0002
494 PRE-EXISTING CONDITION IMPROVED 1 0.0002
495 NASAL DRYNESS 1 0.0002
496 DERMATITIS ALLERGIC 2 0.0002
497 INCOHERENT 1 0.0002
498 HERPES SIMPLEX 1 0.0002
499 SKIN FISSURES 3 0.0002
500 TENDON DISORDER 1 0.0002
501 BRADYPHRENIA 1 0.0002
502 DYSGRAPHIA 1 0.0002
503 DRUG INEFFECTIVE 199 0.0002
504 VIRAL INFECTION 5 0.0002
505 SKIN MASS 1 0.0001
506 POST-TRAUMATIC STRESS DISORDER 1 0.0001
507 INTENTIONAL PRODUCT MISUSE 13 0.0001
508 BRONCHIECTASIS 1 0.0001
509 WRONG PRODUCT ADMINISTERED 1 0.0001
510 VERTIGO 9 0.0001
511 UVEITIS 2 0.0001
512 MIGRAINE 14 0.0001
513 TREATMENT NONCOMPLIANCE 8 0.0001
514 PANIC REACTION 1 0.0001
515 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
516 VISUAL FIELD DEFECT 1 0.0001
517 TONGUE DISORDER 1 0.0001
518 ANOSMIA 2 0.0001
519 INTENTIONAL UNDERDOSE 1 0.0001
520 CHEST DISCOMFORT 14 0.0001
521 NASAL CONGESTION 8 0.0001
522 SENSITIVE SKIN 1 0.0001
523 SKIN HAEMORRHAGE 2 0.0001
524 ARTHROPOD BITE 1 0.0001
525 SNEEZING 3 0.0001
526 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
527 FEELING HOT 8 0.0001
528 FOOD ALLERGY 1 0.0001
529 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
530 APHTHOUS ULCER 1 0.0001
531 SWELLING 12 0.0001
532 FURUNCLE 1 0.0001
533 PRODUCT PRESCRIBING ERROR 3 0.0001
534 RENAL CYST 1 0.0001
535 GINGIVAL PAIN 1 0.0001
536 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
537 MIOSIS 1 0.0001
538 MUSCLE INJURY 1 0.0001
539 VISUAL ACUITY REDUCED 4 0.0001
540 INFUSION SITE ERYTHEMA 1 0.0001
541 SKIN PLAQUE 1 0.0001
542 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
543 PRODUCT COMPLAINT 3 0.0001
544 HYPOPHAGIA 3 0.0001
545 SKIN HYPERPIGMENTATION 1 0.0001
546 CARDIAC OPERATION 1 0.0001
547 MUSCULOSKELETAL DISCOMFORT 2 0.0001
548 DYSPHAGIA 11 0.0001
549 BLOOD MAGNESIUM DECREASED 1 0.0001
550 SKIN SWELLING 1 0.0001
551 DEVICE USE ISSUE 2 0.0001
552 BLOOD CALCIUM INCREASED 1 0.0001
553 DRUG INTOLERANCE 11 0.0001
554 SPINAL OSTEOARTHRITIS 1 0.0001
555 DERMATITIS ATOPIC 6 0.0001
556 EAR INFECTION 3 0.0001
557 HAEMARTHROSIS 1 0.0001
558 ANAL INCONTINENCE 1 0.0001
559 DRY MOUTH 9 0.0001
560 PNEUMONIA BACTERIAL 1 0.0001
561 SKIN DISCOLOURATION 5 0.0001
562 INCREASED TENDENCY TO BRUISE 1 0.0001
563 ANAPHYLACTIC REACTION 6 0.0001
564 PRODUCT DISTRIBUTION ISSUE 1 0.0001
565 FEELING COLD 3 0.0001
566 MIDDLE INSOMNIA 2 0.0001
567 SPUTUM DISCOLOURED 1 0.0001
568 FEELING JITTERY 2 0.0001
569 LETHARGY 6 0.0001
570 COELIAC DISEASE 1 0.0001
571 KIDNEY INFECTION 2 0.0001
572 WHEEZING 6 0.0001
573 HEART RATE INCREASED 10 0.0001
574 CATARACT 6 0.0001
575 BLOOD PRESSURE ABNORMAL 2 0.0001
576 IRRITABILITY 6 0.0001
577 POOR QUALITY DEVICE USED 1 0.0001
578 DRY THROAT 1 0.0001
579 SLUGGISHNESS 1 0.0001
580 TREMOR 16 0.0001
581 VENTRICULAR EXTRASYSTOLES 1 0.0001
582 ROAD TRAFFIC ACCIDENT 4 0.0001
583 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
584 JOINT DISLOCATION 1 0.0001
585 SKIN CANCER 2 0.0001
586 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
587 SKIN LACERATION 1 0.0001
588 PRODUCT DISPENSING ERROR 2 0.0001
589 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
590 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
591 TOOTH FRACTURE 1 0.0001
592 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
593 FOOT DEFORMITY 1 0.0001
594 TOOTH DISORDER 2 0.0001
595 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
596 GAIT INABILITY 3 0.0001
597 NECK PAIN 5 0.0001
598 GLOSSODYNIA 2 0.0001
599 ANGER 3 0.0001
600 CHROMATURIA 2 0.0001
601 APPLICATION SITE PRURITUS 2 0.0001
602 IMPAIRED DRIVING ABILITY 1 0.0001
603 PAIN 54 0.0001
604 PRODUCT AVAILABILITY ISSUE 2 0.0001
605 INTERNAL HAEMORRHAGE 1 0.0001
606 ILLNESS 9 0.0001
607 TINNITUS 4 0.0001
608 SLEEP DISORDER 6 0.0001
609 ATAXIA 1 0.0001
610 NEURALGIA 2 0.0001
611 SPINAL OPERATION 1 0.0001
612 GENERALISED OEDEMA 1 0.0001
613 PHARYNGITIS 1 0.0001
614 CYST 1 0.0001
615 APPLICATION SITE IRRITATION 1 0.0001
616 POISONING 1 0.0001
617 INTESTINAL OBSTRUCTION 3 0.0001
618 BRAIN OEDEMA 1 0.0001
619 INJECTION SITE IRRITATION 1 0.0001
620 ROTATOR CUFF SYNDROME 1 0.0001
621 ANAPHYLACTIC SHOCK 2 0.0001
622 HIATUS HERNIA 1 0.0001
623 NODULE 1 0.0001
624 GASTRITIS 2 0.0001
625 SARS-COV-2 TEST POSITIVE 1 0.0001
626 PAIN OF SKIN 2 0.0001
627 BLINDNESS 3 0.0001
628 GINGIVAL BLEEDING 1 0.0001
629 HYPOMAGNESAEMIA 1 0.0001
630 COORDINATION ABNORMAL 1 0.0001
631 HOSPITALISATION 11 0.0001
632 WOUND 2 0.0001
633 MASS 1 0.0001
634 CARPAL TUNNEL SYNDROME 1 0.0001
635 SKIN REACTION 1 0.0001
636 SEASONAL ALLERGY 1 0.0001
637 PAIN IN JAW 2 0.0001
638 INCORRECT DOSE ADMINISTERED 16 0.0001
639 BALANCE DISORDER 6 0.0001
640 MENTAL DISORDER 3 0.0001
641 DYSSTASIA 2 0.0001
642 SINUSITIS 7 0.0001
643 DYSPNOEA 38 0.0001
644 EPISTAXIS 5 0.0001
645 FEELING ABNORMAL 16 0.0001
646 BLOOD POTASSIUM DECREASED 2 0.0001
647 ACNE 5 0.0001
648 ABDOMINAL DISCOMFORT 11 0.0001
649 CHEST PAIN 12 0.0001
650 ANKLE FRACTURE 1 0.0001
651 TENDONITIS 1 0.0001
652 DELUSION 1 0.0001
653 EJECTION FRACTION DECREASED 1 0.0001
654 COGNITIVE DISORDER 3 0.0001
655 BASAL CELL CARCINOMA 1 0.0001
656 NERVOUS SYSTEM DISORDER 2 0.0001
657 MENINGIOMA 1 0.0001
658 PARAESTHESIA 10 0.0001
659 ABDOMINAL PAIN UPPER 13 0.0001
660 SCIATICA 1 0.0001
661 CONTUSION 6 0.0001
662 SENSORY DISTURBANCE 1 0.0001
663 INFECTION 9 0.0001
664 NIGHT SWEATS 2 0.0001
665 MUSCLE TIGHTNESS 1 0.0001
666 BLOOD POTASSIUM INCREASED 1 0.0001
667 INSOMNIA 16 0.0001
668 FUNGAL INFECTION 2 0.0001
669 BLOOD UREA INCREASED 1 0.0001
670 CELLULITIS 3 0.0001
671 CANDIDA INFECTION 1 0.0001
672 BLOOD PRESSURE INCREASED 9 0.0001
673 NAUSEA 46 0.0001
674 DEVICE USE ERROR 2 0.0001
675 NERVOUSNESS 3 0.0001
676 HEART RATE DECREASED 2 0.0001
677 COLD SWEAT 1 0.0001
678 DRUG INTERACTION 9 0.0001
679 LYMPHADENOPATHY 2 0.0001
680 INJECTION SITE ERYTHEMA 7 0.0001
681 GALLBLADDER DISORDER 1 0.0001
682 DISTURBANCE IN ATTENTION 3 0.0001
683 GASTROENTERITIS VIRAL 1 0.0001
684 TOOTHACHE 1 0.0001
685 CRYING 2 0.0001
686 CONSTIPATION 12 0.0001
687 PANIC ATTACK 2 0.0001
688 SOMNOLENCE 11 0.0001
689 BRONCHITIS 4 0.0001
690 THINKING ABNORMAL 1 0.0001
691 COUGH 15 0.0001
692 ASTHMA 6 0.0001
693 HALLUCINATION 4 0.0001
694 FOOT FRACTURE 1 0.0001
695 DRY SKIN 7 0.0001
696 INCREASED APPETITE 1 0.0001
697 HERPES ZOSTER 3 0.0001
698 ACUTE RESPIRATORY FAILURE 1 0.0001
699 PERIPHERAL SWELLING 8 0.0001
700 PRESCRIBED OVERDOSE 1 0.0001
701 EAR PAIN 1 0.0001
702 HAEMORRHOIDS 1 0.0001
703 DISORIENTATION 2 0.0001
704 UPPER LIMB FRACTURE 1 0.0001
705 INJURY ASSOCIATED WITH DEVICE 1 0.0000
706 BODY TEMPERATURE INCREASED 1 0.0000
707 KNEE ARTHROPLASTY 1 0.0000
708 MOUTH ULCERATION 1 0.0000
709 HALLUCINATION, VISUAL 1 0.0000
710 OSTEOARTHRITIS 2 0.0000
711 EATING DISORDER 1 0.0000
712 RETCHING 1 0.0000
713 JOINT INJURY 1 0.0000
714 HYPOAESTHESIA 7 0.0000
715 IRRITABLE BOWEL SYNDROME 1 0.0000
716 HYPERHIDROSIS 6 0.0000
717 POOR QUALITY SLEEP 1 0.0000
718 FAECES DISCOLOURED 1 0.0000
719 BLOOD CREATININE INCREASED 3 0.0000
720 MUSCULOSKELETAL STIFFNESS 4 0.0000
721 MALAISE 20 0.0000
722 BLOOD PRESSURE DECREASED 3 0.0000
723 RASH MACULO-PAPULAR 1 0.0000
724 INFLUENZA 5 0.0000
725 ORAL PAIN 1 0.0000
726 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
727 RASH PAPULAR 1 0.0000
728 HEART RATE IRREGULAR 1 0.0000
729 MUSCLE TWITCHING 1 0.0000
730 ARTHRALGIA 18 0.0000
731 HYPERTENSION 9 0.0000
732 DEATH 36 0.0000
733 BLOOD GLUCOSE DECREASED 2 0.0000
734 MENTAL IMPAIRMENT 1 0.0000
735 PRESYNCOPE 1 0.0000
736 ALOPECIA 8 0.0000
737 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
738 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
739 FLUSHING 4 0.0000
740 LOSS OF CONSCIOUSNESS 5 0.0000
741 INFLAMMATION 2 0.0000
742 HAEMATOMA 1 0.0000
743 ABDOMINAL DISTENSION 4 0.0000
744 DEAFNESS 1 0.0000
745 ECZEMA 2 0.0000
746 SPEECH DISORDER 2 0.0000
747 ARTHRITIS 3 0.0000
748 NASOPHARYNGITIS 7 0.0000
749 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
750 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
751 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
752 LIMB INJURY 1 0.0000
753 MOOD ALTERED 1 0.0000
754 DIVERTICULITIS 1 0.0000
755 PROCEDURAL PAIN 1 0.0000
756 MENTAL STATUS CHANGES 1 0.0000
757 URINARY TRACT INFECTION 6 0.0000
758 PYREXIA 12 0.0000
759 COVID-19 6 0.0000
760 BONE PAIN 2 0.0000
761 SURGERY 2 0.0000
762 URINARY INCONTINENCE 1 0.0000
763 GASTROINTESTINAL DISORDER 3 0.0000
764 APHASIA 1 0.0000
765 EPILEPSY 1 0.0000
766 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
767 HEAD INJURY 1 0.0000
768 CYSTITIS 1 0.0000
769 GAIT DISTURBANCE 6 0.0000
770 MOVEMENT DISORDER 1 0.0000
771 CONFUSIONAL STATE 5 0.0000
772 ATRIAL FIBRILLATION 3 0.0000
773 PAIN IN EXTREMITY 9 0.0000
774 IMPAIRED HEALING 1 0.0000
775 STAPHYLOCOCCAL INFECTION 1 0.0000
776 FALL 10 0.0000
777 SKIN DISORDER 1 0.0000
778 HYPOTENSION 6 0.0000
779 INJECTION SITE PRURITUS 2 0.0000
780 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
781 FATIGUE 23 0.0000
782 HEPATIC ENZYME INCREASED 2 0.0000
783 ASTHENIA 11 0.0000
784 INJECTION SITE REACTION 2 0.0000
785 NIGHTMARE 1 0.0000
786 DEVICE MALFUNCTION 2 0.0000
787 INJURY 2 0.0000
788 MOBILITY DECREASED 2 0.0000
789 ACCIDENTAL OVERDOSE 1 0.0000
790 RESTLESSNESS 1 0.0000
791 DYSURIA 1 0.0000
792 INJECTION SITE MASS 1 0.0000
793 DYSPNOEA EXERTIONAL 1 0.0000
794 MUSCULAR WEAKNESS 3 0.0000
795 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
796 BACK PAIN 6 0.0000
797 PLASMA CELL MYELOMA 1 0.0000
798 INJECTION SITE BRUISING 2 0.0000
799 JOINT SWELLING 3 0.0000
800 PNEUMONIA 8 0.0000
801 PSORIATIC ARTHROPATHY 1 0.0000
802 DYSKINESIA 1 0.0000
803 ANXIETY 7 0.0000
804 INFLUENZA LIKE ILLNESS 2 0.0000
805 MYALGIA 4 0.0000
806 SEPTIC SHOCK 1 0.0000
807 INJECTION SITE PAIN 7 0.0000
808 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
809 COLITIS ULCERATIVE 1 0.0000
810 PULMONARY OEDEMA 1 0.0000
811 PRODUCT QUALITY ISSUE 3 0.0000
812 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
813 MEMORY IMPAIRMENT 3 0.0000
814 DIARRHOEA 14 0.0000
815 DECREASED APPETITE 5 0.0000
816 ABDOMINAL PAIN 5 0.0000
817 RENAL DISORDER 1 0.0000
818 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
819 CARDIAC DISORDER 2 0.0000
820 ARRHYTHMIA 1 0.0000
821 PRODUCTIVE COUGH 1 0.0000
822 INTERSTITIAL LUNG DISEASE 1 0.0000
823 DYSPEPSIA 2 0.0000
824 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
825 VOMITING 9 0.0000
826 HAEMORRHAGE 2 0.0000
827 PANCREATITIS 1 0.0000
828 DEPRESSED MOOD 1 0.0000
829 OEDEMA 1 0.0000
830 ARTHROPATHY 1 0.0000
831 MEDICATION ERROR 1 0.0000
832 SEPSIS 2 0.0000
833 PANCYTOPENIA 1 0.0000
834 OXYGEN SATURATION DECREASED 1 0.0000
835 HYPONATRAEMIA 1 0.0000
836 SEIZURE 2 0.0000
837 MYOCARDIAL INFARCTION 3 0.0000
838 CHILLS 2 0.0000
839 DISEASE PROGRESSION 2 0.0000
840 NO ADVERSE EVENT 3 0.0000
841 STOMATITIS 1 0.0000
842 MUSCLE SPASMS 3 0.0000
843 ANAEMIA 3 0.0000
844 AMNESIA 1 0.0000
845 PSORIASIS 2 0.0000
846 FEBRILE NEUTROPENIA 1 0.0000
847 DEHYDRATION 2 0.0000
848 WEIGHT DECREASED 4 0.0000
849 UNDERDOSE 1 0.0000
850 AGITATION 1 0.0000
851 WEIGHT INCREASED 3 0.0000
852 HOT FLUSH 1 0.0000
853 CHRONIC KIDNEY DISEASE 1 0.0000
854 CARDIAC FAILURE CONGESTIVE 1 0.0000
855 PROSTATE CANCER 1 0.0000
856 TREATMENT FAILURE 1 0.0000
857 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
858 RENAL IMPAIRMENT 1 0.0000
859 SUICIDAL IDEATION 1 0.0000
860 BLOOD GLUCOSE INCREASED 2 0.0000
861 NEUROPATHY PERIPHERAL 1 0.0000
862 SYNCOPE 1 0.0000
863 RHEUMATOID ARTHRITIS 1 0.0000
864 DEPRESSION 2 0.0000
865 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
866 EMOTIONAL DISTRESS 1 0.0000
867 OEDEMA PERIPHERAL 1 0.0000
868 ACUTE KIDNEY INJURY 1 0.0000
869 TOXICITY TO VARIOUS AGENTS 1 0.0000
870 CEREBROVASCULAR ACCIDENT 1 0.0000
871 OVERDOSE 1 0.0000